Interleukin-6-Rezeptorblocker Tocilizumab zugelassen
Interleukin-6: obstacles to targeting a complex cytokine in critical illness - The Lancet Respiratory Medicine
Interleukin-6 Receptor Inhibitors for the Treatment of Rheumatoid Arthritis - Rheumatology Advisor
Machen Interleukin-Inhibitoren krank?
Frontiers | Interleukin-1 Inhibitors and Vaccination Including COVID-19 in Inflammatory Rheumatic Diseases: A Nonsystematic Review
Pharmacologic interleukin (IL)-1 and IL-6 inhibitors. IL-1β and IL-1α... | Download Scientific Diagram
Hoch effektiv gegen Entzündungen | PZ – Pharmazeutische Zeitung
Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases | Nature Reviews Drug Discovery
Interleukin-1 Inhibition at Treatment for Rheumatoid Arthritis on Johns Hopkins Arthritis
Interleukin-1 (IL-1) receptor blockers in rheumatoid arthritis (RA) | Download Table
Interleukin-1 and interleukin-6 inhibition compared with standard management in patients with COVID-19 and hyperinflammation: a cohort study - The Lancet Rheumatology
Rheumatoide Arthritis: Hohe Ansprechraten mit Interleukin-6-Hemmer
Interleukin Inhibitor Cheatsheet
Interleukin-6 und RA
Interleukin-1 Inhibition at Treatment for Rheumatoid Arthritis on Johns Hopkins Arthritis
Understanding the Role of Interleukin-6 (IL-6) in the Joint and Beyond: A Comprehensive Review of IL-6 Inhibition for the Management of Rheumatoid Arthritis | SpringerLink
Interleukin-1-Blocker: Evidenz spricht nicht für deutliche Wirkung bei COVID-19 | Cochrane Deutschland
Blockade von Interleukin 6 - 12 - 2017 - Heftarchiv - AMT
Immunomodulatory and protective effects of interleukin-4 on the neuropathological alterations induced by a potassium channel blocker - ScienceDirect
Tocilizumab does not block interleukin-6 (IL-6) signaling in murine cells | PLOS ONE
Interleukin-1 Inhibition at Treatment for Rheumatoid Arthritis on Johns Hopkins Arthritis
Interleukin-6 (IL-6) – rheuma-online
The role of IL-6 in host defence against infections: immunobiology and clinical implications | Nature Reviews Rheumatology
Interleukin-1 Inhibition at Treatment for Rheumatoid Arthritis on Johns Hopkins Arthritis
The Society for Immunotherapy of Cancer perspective on regulation of interleukin-6 signaling in COVID-19-related systemic inflammatory response | Journal for ImmunoTherapy of Cancer
Behandlung mit Interleukin-17-Blockern: Das sollten Sie wissen! | Rheuma-Liga Hamburg
A Small-Molecule Inhibitor to the Cytokine Interleukin-4 | ACS Chemical Biology
Targeting Interleukin-6: All the Way to Treat Autoimmune and Inflammatory Diseases
Hoch effektiv gegen Entzündungen | PZ – Pharmazeutische Zeitung
